Martínez-Duncker RC, Hurtado-López LM

Idioma: Español
Referencias bibliográficas: 18
Paginas: 67-71
Archivo PDF: 113.89 Kb.

FRAGMENTO

En medicina es aceptado generalmente que, cuando se desea confirmar la presencia de una enfermedad, se prefieren las pruebas diagnósticas más específicas (una prueba que, de ser positiva, confirme la enfermedad) mientras que, cuando se requiere descartar una enfermedad, se prefieren las pruebas diagnósticas más sensibles (un resultado que de ser negativo descarte la enfermedad).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Lee WC. Selecting diagnostic tests for ruling out or ruling in disease: the use of the Kullback-Leibler distance. Int J Epidemiol 1999; 28: 521-525.

2. Espallardo N. Decisions on diagnosis in family practice: Use of sensitivity, specificity, predictive values and likelihood ratios. Asia Pacific Family Medicine 2003; 2: 229-232.

3. Bowyer A. Quantitative information of specific diagnostic tests. J Med Syst 1988; 22: 3-13.

4. Dendukuri N, Rahme E, Belisle P, Joseph L. Bayesian sample size determination for prevalence and diagnostic test studies in the absence of a gold standard test. Biometrics 2004: 60: 388,397.

5. Schmidt M, Eschner W, Dietlein M, Theissen P, Schicha H. Established nuclear medicine techniques for tumour diagnosis (tumour SPECT): can they still compete with (18)F-FDG-PET? Nuklearmedizin 2005; 44: 37-48.

6. AACE/AME Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 2006; 12: 63-102.

7. Hurtado-López LM, Arellano-Montaño S, Torres-Acosta EM, Zaldivar- Ramirez FR, Duarte Torres RM, Alonso-de-Ruiz P, et al. Combined use of fine needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging 2004; 31: 1273-1279.

8. Matull WR, Pereira SP, O’Donohue JW. Biochemical markers of acute pancreatitis. J Clin Pathol 2006; 59(4): 340-344.

9. Pilleul F, Bansac-Lamblin A, Monneuse O, Dumortier J, Milot L, Valette PJ. Water enema computed tomography: diagnostic tool in suspicion of colorectal tumor. Gastroenterol Clin Biol 2006; 30: 231-234.

10. Yu CY, Lin CC, Shyu RY, Hsieh CB, Wu HS, Tyan YS, et al. Value of CT in the diagnosis and management of gallstone ileus. World J Gastroenterol 2005; 11: 2142-2147.

11. Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 head and neck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope 2006; 112(3 Pt 2 Suppl 109): 1-15.

12. Gallegos-Hernandez JF, Chavez-Garcia M. [Usefulness of lymphatic mapping with sub-areolar injection of patent blue dye, in the typification of breast cancer]. Rev Invest Clin 2003; 55: 407-11.

13. Porter RS, Nester BA, Dalsey WC, O’Mara M, Gleeson T, Pennell R, Beyer FC. Use of ultrasound to determine need for laparotomy in trauma patients. Ann Emerg Med 1997; 29: 323-330.

14. Ruiz Franco-Baux JV, Borrego Dorado I, Gomez Camarero P, Rodriguez Rodríguez JR, Vazquez Albertino RJ, Navarro González E, et al. [F-18-fluordeoxyglucose positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan]. Rev Esp Med Nucl 2005; 24: 5-13.

15. Miller WC. Bias in discrepant analysis: when two wrongs don’t make a right. J Clin Epidemiol 1998; 51: 219-231.

16. Jerjes-Sánchez CD, Elizalde González JJ, Sandoval Zárate J, Gutiérrez Fajardo P, García de León MS, Ramirez Rivera A, et al. Diagnóstico, estratificación y tratamiento de la tromboembolia pulmonar aguda: Guías y Recomendaciones del Capítulo de Circulación Pulmonar de la Sociedad Mexicana de Cardiología. Arch Cardiol Mex 2004; 74(S3): S547-S585.

17. Parker JA, Coleman RE, Hilson AJW, et al. Society of Nuclear Medicine Procedure Guideline for Lung Scintigraphy Version 3.0, approved February 7, 2004.

18. Consenso mexicano sobre enfermedad tromboembólica venosa. Cir Cir 2000; 68(S6): S7-S29.